Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

• Published in: Diabetes therapy Vol. 14; no. 7; pp. 1077 - 1091
• Main Authors: Tejera-Pérez, Cristina, Chico, Ana, Azriel-Mira, Sharona, Lardiés-Sánchez, Beatriz, Gomez-Peralta, Fernando
• Format: Journal Article
• Language: English
• Published: Cheshire Springer Healthcare 01.07.2023; Springer; Springer Nature B.V
• Subjects: Cardiology; Diabetes; Dosage and administration; Drug delivery devices; Drug therapy; Endocrinology; Guidelines; Insulin; Internal Medicine; Medicine; Medicine & Public Health; Practice guidelines (Medicine); Quality of life; Type 1 diabetes; Type 2 diabetes; Spain; Connected insulin pens; Digital health; Diabetes; Multiple daily insulin therapy; Connected insulin caps
• ISSN: 1869-6953; 1869-6961; 1869-6961
• DOI: 10.1007/s13300-023-01417-1

Undoubtedly, technological advances have revolutionised diabetes management in recent years. The development of advanced closed hybrid loop insulin pumps or continuous glucose monitoring (CGM) systems, among others, have increased the quality of life and improved glycaemic control of people with diabetes. However, only some patients have access to such technology, and only some want to use it. CGM has become much more widespread, but in terms of insulin delivery, most people with type 1 diabetes (T1D) and almost all people with type 2 diabetes (T2D) on insulin therapy are treated with multiple-dose insulin injections (MDI) rather than an insulin pump. For these patients, using connected insulin pens or caps has shown benefits in reducing missed insulin injections and promoting correct administration over time. In addition, using these devices improves the quality of life and user satisfaction. The integration of insulin injection and CGM data facilitates both users and the healthcare team to analyse glucose control and implement appropriate therapeutic changes, reducing therapeutic inertia. This expert’s recommendation reviews the characteristics of the devices marketed or in the process of being marketed and their available scientific evidence. Finally, it suggests the profile of users and professionals who would benefit most, the barriers to its generalisation and the changes in the care model that implementing these devices can bring with it.